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Abstract  
AIM: This study was conducted to investigate the correlation between waist/hip ratio (WHR) as a measurement of 
obesity and severity of coronary artery disease (CAD) assessed by angiography in Kosovo. 
METHODS: The study included 82 patients with suspected or known CAD who were referred for coronary 
angiography. All patients were subjected to full individual medical history, clinical examination including 
measurement of arterial blood pressure, body weight, height, body mass index (BMI), waist circumference, hip 
circumference, waist/hip ratio, and waist/height ratio. Coronary angiography was performed using standard 
techniques to determine the presence and severity of coronary artery lesions with the Gensini score. 
RESULTS: Among the 82 patients in the study, the mean age in the CAD group was 66.76 ± 9.12 years and the 
mean age in the non-CAD group was 64.80 ± 8.30 years. Patients in the CAD group had a mean BMI of 28.17 ± 
3.32 kg/m
2
 and those in the non-CAD group had a mean BMI of 28.76 ± 4.68 kg/m
2
. Patients in the CAD group 
had a mean waist/height ratio of 1.76 ± 7.56 and those in the non-CAD group had a mean waist/height ratio of 
0.57 ± 0.08. Patient in the CAD group had a mean waist/hip ratio of 0.93 ± 0.06 and those in the non-CAD group 
had a mean waist/hip ratio of 0.88 ± 0.07. Thirty-seven patients (45.1%) had no coronary artery disease (Gensini 
score = 0), 15 (18.3%) had mild disease (Gensini score = 1-32), 14 (17.1%) had moderate disease (Gensini score 
= 32-58), and 16 (19.5%) had severe disease (Gensini score ≥ 58). 
CONCLUSION: There was a significant positive correlation between waist/hip ratio and presence of CAD in 
Kosovar patients. 
 
 
 
 
Introduction 
 
Obesity is a growing health problem in most 
developed and in some developing countries. It is a 
very important risk factor for cardiovascular diseases 
as well as for type 2 diabetes mellitus and 
hypertension. Different methods exist for clinical 
evaluation of obesity. The body mass index (BMI), 
waist circumference (WC), waist/hip ratio (WHR), and 
waist/height ratio (WHtR) are some of the clinical tools 
enabling health teams to evaluate obesity and fat 
distribution. A central fat distribution is considered 
more atherogenic than peripheral obesity and 
attention has been paid to methods that can clinically 
evaluate central obesity [1]. The incidence of obesity 
is increasing in developing countries because of the 
westernization of diet and lifestyle [2]. 
Obesity is a proven independent risk factor for 
CAD in both sexes, and is in general a growing health 
problem [3-5]. Body weight, BMI, WC, and WHR are 
primary methods used to determine obesity. While 
BMI reflects general obesity, WC and WHR are 
related to central-type obesity, where body fat is 
primarily located in the abdomen. Prospective 
epidemiological studies have revealed that central 
obesity (determined by WC and WHR) is more 
relevant to CAD risk compared to general obesity 
(determined by BMI). While WHR is used commonly 
to evaluate central obesity, WC is shown to have a 
better correlation with abdominal fat localization (6-9). 
However, it also has been argued that BMI does not 
adequately reflect body fat distribution, and abdominal 
obesity, which captures the distribution of fat mass, 
may be an even more important predictor of CAD [10, 
11].  
In epidemiological settings WC, WHR, and 
WHtR are used as markers of visceral fat mass or 
abdominal adiposity to assess CAD risk.  
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To the best of our knowledge, this is the first 
study performed in Kosovo to focus on the correlation 
between WHR and the presence of CAD. 
 
 
Material and Methods 
 
Subjects of the study 
The study was approved by the Ethics 
Committee of the Faculty of Medicine in the University 
of Prishtina, in accordance with the Declaration of 
Helsinki Guidelines. Written consent was obtained 
from all participants in the study. The prospective 
study consisted of 82 patients who underwent 
coronary angiography for suspected or known 
coronary atherosclerosis. Patients had to be clinically 
stable without major concomitant non-cardiovascular 
disease on assessment at the University Clinical 
Center of Kosovo. Patients with acute coronary 
syndrome, heart valve disease, elevated serum 
troponin levels, severe heart failure, chronic renal 
failure, and chronic inflammatory disease were 
excluded from the study.   
 
Coronary angiography 
Single-vessel disease was defined as > 50% 
luminal stenosis in a minimum of two views. Two 
experienced reviewers scored the angiograms. In 
case of disagreement between the reviewers, the 
average value of both angiograms was chosen. 
Reviewers were not aware of the diagnosis. 
Narrowing of the coronary artery lumen is assigned a 
Gensini score [12]. The score is 1 for 1-25% 
narrowing, 2 for 26-50%, 4 for 51-75%, 8 for 76-90%, 
16 for 91-99%, and 32 for a completely occluded 
artery. The primary score is multiplied by a factor that 
takes into account the importance of the position of 
the lesion in the coronary arterial tree. For example, 
1.5 is the multiplication factor for a mid-left anterior 
descending artery (LAD) lesion, with 1 for distal LAD, 
2.5 for proximal LAD, and 5 for left main stem lesions. 
The Gensini score was expressed as the sum of the 
scores for all three coronary arteries to evaluate the 
overall extent of coronary artery disease [12]. 
 
Measurements  
Patients were assessed in an examination 
gown, with upper body clothing and shoes removed. 
Each measurement was performed twice and the 
average was used for the analysis. We used the 
nearest 0.1 units of measurement for height and 
weight. BMI and WHtR were expressed in 
corresponding units, i.e., weight (kg) divided by the 
square of height (m
2
), and waist circumference divided 
by height. WC was also categorized according to 
World Health Organization (WHO) criteria [13]. For the 
WHR, the waist is measured between the lowest rib 
and iliac crest, and the hip circumference is taken at 
the widest area of the hips at the greatest 
protuberance of the buttocks. The waist measurement 
is then divided by the hip measurement. For the 
decisive benchmark of metabolic syndrome, the WHO 
uses the ratio of > 9.0 in men and > 8.5 in women. 
Laboratory measurements and blood samples 
were taken in the morning after an overnight fast and 
were stored immediately at -70°C after centrifugation 
until being assayed.  
 
Statistics 
The data were entered and analyzed with 
Statistical Package for the Social Science (SPSS), 
version 22 (SPSS Inc., Chicago, IL, USA). Continuous 
variables were primarily analyzed using a t-test, while 
binary data were primarily analyzed using a chi-
squared test. Continuous variables were presented as 
means ± standard deviation (SD). Additionally, single 
(unadjusted) and multiple (adjusted) binary logistic 
regression analysis was carried out with the CAD 
group as the dependent variable, and the other 
significant variables as independent predictors. A p 
value of 0.1 was used as a criterion to identify 
variables for inclusion in the binary logistic regression 
models. Other adjusting variables included diastolic 
blood pressure (DBP), WHR, male sex, and smoking. 
 
 
Results 
 
Among the 82 patients in the study, the mean 
age was 65.78 ± 12.86 years, 46 patients (56.1%) 
were males, and 36 (43.9%) were females. Sixty-two 
patients (75%) had hypertension, 29 (35%) had 
diabetes mellitus, and 23 (28%) had dyslipidemia. 
Family history of CAD was positive in 42 patients 
(51%).  
Patients in the CAD group had a mean BMI of 
28.17 ± 3.32 kg/m
2
 and those in the non-CAD group 
had a mean BMI of 28.76 ± 4.68 kg/m
2
. Patients in the 
CAD group had a mean WC of 96.97 ± 8.63 cm and 
those in the non-CAD group had a mean WC of 95.13 
± 11.52 cm. Patients in the CAD group had a mean 
WHtR of 1.76 ± 7.56 and those in the non-CAD group 
had a mean WHtR of 0.57 ± 0.08. The mean WHR 
was 0.93 ± 0.06 in the CAD group and 0.88 ± 0.07 in 
the non-CAD group. The number of male patients in 
the study group was significantly higher (n = 29, 
70.7%) than in the control group (n = 17, 41.5%) (p = 
0.008). 
WHR values in the study group (mean 0.93 ± 
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0.06) and control group (mean 0.88 ± 0.07) were 
significant (p-value: 0.0001), as shown in Table 1. 
Table 1: Demographic and clinical characteristics of non-CAD 
and CAD groups  
Variables Group I  
Non-CAD 
Group II  
CAD 
p value* 
 (n = 41) (n = 41) 
BMI (kg/m
2
) (mean ± SD) 28.76 ± 4.68  28.17 ± 3.32  0.51 
WC (cm) 95.13 ± 11,52  96.97 ± 8.63  0.44 
WHtR (mean ± SD) 0.57 ± 0.08  1.76 ± 7.56  0.32 
WHR (mean ± SD) 0.88 ± 0.07  0.93 ± 0.06  0.0001* 
SBP (mmHg1 (mean ± SD) 145.61 ± 13.29  145.85 ± 11.98  0.93 
DBP (mmHg2 (mean ± SD) 81.34 ± 7.75  84.88 ± 7.79  0.042* 
Age (mean ± SD) 64.80 ± 8.30  66.76 ± 9.12  0.31 
Sex (M), n (%) 17  41.5%  29  70.7%  0.008* 
*, Statistically significant differences; n=Number. 
 
Table 2 presents the unadjusted and adjusted 
odd ratios (ORs) of CAD according to waist/hip ratio. 
After adjusting for confounder variables, the odds of 
having CAD were increased 14-fold (95% confidence 
interval [CI], 0.94-207.60), compared to those with a 
WHR <0.8.  
In patients with a WHR of 0.8-0.99, the odds 
of having CAD significantly increased by 3.77-fold 
(95% CI, 0.40-35.51) compared to those with a WHR 
<0.8.  
Significant differences were seen in binary 
logistic regression models for CAD analysis according 
to WHR (OR 14; 95% CI 0.94-207.60; p = 0.06), DBP 
(OR 2.75; 95% CI 1.12-6.87; p = 0.03), male sex (OR 
3.41; 95% CI 1.37-8.52; p = 0.01), and smoking (OR 
4.15; 95% CI 1.65-10.44; p = 0.001). 
Table 2: Binary Logistic Regression Models for CAD 
(Unadjusted and Adjusted), DBP, WHR 
  Unadjusted p value   Adjusted p value 
  Odds Ratio (95% CI)   Odds Ratio (95% CI) 
DBP ≥ 90 mmHg2 2.75 (1.12-6.87) 0.03  3.35 (1.05-10.69) 0.04 
WHR < 0.8 1.00 (Reference) 0.13  1.00 (Reference) 0.67 
          0.8 - 0.99 3.77 (0.40-35.51) 0.25  3.42 (0.23-50.38) 0.37 
          ≥ 1 14 (0.94-207.60) 0.06  3.03 (0.13-71.20) 0.49 
Sex (Male) 3.41 (1.37-8.52) 0.01  2.9 (0.81-10.35) 0.10 
Smoker 4.15 (1.65-10.44) 0.00   3.51 (0.98-12.52) 0.05 
             
 
Thirty-seven patients (45.1%) had no CAD 
(Gensini score = 0), 15 (18.3%) had mild disease 
(Gensini score = 1-32), 14 patients (17.1%) had 
moderate disease (Gensini score = 32-58), and 16 
(19.5%) had severe disease (Gensini score ≥ 58). 
There was non-significant correlation between Gensini 
score and body mass index (p-value= 0.115) as 
shown in (Table 3). 
Table 3. Correlation between BMI and Gensini 
                 
Gensini 
BMI 
Total Normal Overweight Obese 
18-24.9 (kg/m
2)
 25-29.9 (kg/m
2
) ≥30 (kg/m
2
) 
N % N % N % N % 
None (0) 7 46.7 13 35.1 17 56.7 37 45.1 
Mild (1-32) 3 20 11 29.7 1 3.3 15 18.3 
Moderate (32-58) 1 6.7 6 16.2 7 23.3 14 17.1 
Severe (≥58) 4 26.7 7 18.9 5 16.7 16 19.5 
Total 15 100 37 100 30 100 82 100 
chi-square test, P-value 0.115 
Discussion 
 
The current study showed a significant 
correlation between WHR and CAD (p = 0.0001) but 
not between BMI and CAD. This may be explained by 
the fact that BMI quantifies general adiposity; although 
individuals who are overweight or obese are likely to 
have excess fat, BMI does not give an indication of 
how this fat is distributed in the body. However, fat 
distribution is an important determinant of CAD, 
independent of BMI and other classic risk factors for 
CAD [14]. Welborn and Dhaliwal [15] and Srikanthan, 
Seeman, and Karlamangla [16] confirmed that WHR 
was a superior clinical measurement for predicting all-
cause and cardiovascular disease mortality. 
Furthermore, one report [15] stated that the hip 
circumference indicated a lower risk for body fat 
accumulation, and thus including it in the WHR 
equation enhances the accuracy of measurement. It 
should be emphasized that most of the cross-
sectional studies that compared WHR and WC as 
markers of risk factors have demonstrated superiority 
of WHR [6, 17].  
The International Diabetes Federation has 
recommended waist circumference thresholds for 
increased risk of cardiovascular disease and diabetes: 
≥ 94 cm in men and ≥ 80 cm in women. The American 
Heart Association (AHA) and National Heart, Lung, 
and Blood Institute (NHLBI) set the thresholds at ≥ 
102 cm in men and ≥88 cm in women [7]. Cameron et 
al. [8] reported that higher WC was associated with 
increased risk in men but not in women, when 
adjusted for BMI and other covariates. That report 
was part of a prospective study of 6,072 Australian 
men and women during a follow-up period of 5 years 
[8]. Our study did not show a significant correlation of 
sex with WC but demonstrated that male sex is a 
significant risk factor for CAD (p = 0.008). In a large 
cohort study across Europe that involved patients of 
both sexes with a follow-up period of 9 years, Pischon 
et al. reported that higher WC (in men and women) 
and WHR (in women but not in men) were associated 
with higher mortality due to ischemic heart disease 
[11].  
In a large cohort study of 1,346 middle-aged 
men free of CVD at baseline followed for 10.6 years, 
WHR, WC, and BMI were all directly associated with 
the risk of coronary events, with WHR providing 
additional information beyond BMI in predicting CAD, 
whereas BMI did not add to the predictive value of 
WHR [18].  
WC, WHR and WHtR are used as measures 
of central obesity, while BMI is generally used to 
measure overall obesity. 
Molarius and Seidell [19] emphasized the 
need to examine whether there could be age-related 
differences in the contribution of the pattern of fat 
distribution to risk factors. However, the WHO and 
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NHLBI reports barely address the question of the 
applicability of BMI and WC standards for older 
persons. 
Several authors have reported the CAD risk 
associated with BMI, WC, WHR, or WHtR and have 
systematically compared some or all of these 
indicators to predict CAD [20-25]. 
Current studies confirm that obesity measured 
by any index usually is associated with increased risk 
of CAD. However, the findings comparing different 
measurements of total obesity (BMI) and abdominal 
obesity (WC, WHR, WHtR) in predicting CAD events 
have not been consistent. Some have suggested that 
total obesity rather than abdominal obesity is a better 
predictor of CAD [24, 25]. However, some 
investigators have found the reverse to be true [20, 
23], and others did not find any significant difference 
(21, 22). This inconsistency in findings could be due to 
a number of reasons. There can be errors in self-
reported measurements in some studies that can 
either cause spurious associations or can bias results 
towards the null. Inadequate or over adjustment of 
confounders and other cardiovascular risk factors also 
play a role in determining the nature of this 
association. Fat distribution and susceptibility to CAD 
vary by age, sex, and ethnicity and can cause these 
differences in the results as well. 
Similar to our study, the Health Professionals 
Follow-up Study showed that WHR was a better 
predictor of CAD risk than BMI among elderly 
subjects; however, for young patients, BMI was a 
better predictor [26]. BMI was not a significant factor 
in our study, reinforcing the findings of Rimm et al. A 
possible explanation for our findings could be that the 
mean age was 65.78 ± 12.86 years in our population, 
and we did not include young patients.  
Longer follow-up in the Health Professionals 
Study and the Nurses’ Health Study also showed that 
WC was a better predictor of CAD risk than BMI 
among men and women above age 60, and BMI was 
more strongly associated with risk of CAD in younger 
compared to older participants [10]. WHR was 
proposed as the preferred measure of obesity for 
prediction of cardiovascular disease, with more 
universal application in individuals and population 
groups of different body builds. Benchmark studies of 
WHR as a dominant cardiovascular risk factor were 
reported in Swedish men and women in 1984 [10, 27]. 
Although a relatively small sample of patients 
were selected randomly from the general population, 
we showed a significant relationship between WHR 
and CAD. Further studies with larger patient groups 
are necessary to show statistical differences between 
BMI, WC, WHtR, WHR, systolic blood pressure 
(SBP), DBP, age, and sex.  
In conclusion, there is a significant positive 
correlation between WHR and the presence and 
severity of CAD among Kosovar patients. Abdominal 
obesity is an independent risk factor for CAD and is 
more relevant than overall obesity. Since both total 
obesity and abdominal adiposity were associated with 
development of CAD, and since measurement of WC, 
WHR, WHtR, and BMI are inexpensive; we propose to 
include these in the general clinical setting for CAD 
risk assessment. 
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